...a senior executive of Cephalon Inc. and US Oncology Inc....

...to participate in clinical trials of candidates from Amgen's pipeline. The initiative's first partners are US Oncology...

...the pharma expects a decision next half. On a conference call Monday, Head of Novartis US Oncology...

...commercial officer, a newly created position. Bogle was EVP of strategy and emerging businesses at US Oncology Inc....

...as EVP and general counsel. Most recently, Osborn was general counsel for oncology services company US Oncology Inc....

...John Osborn as EVP, general counsel and corporate secretary, formerly EVP and general counsel of US Oncology Inc....

...EVP, general counsel and corporate secretary. He is the former EVP and general counsel of US Oncology Inc....

...a medical breast oncologist at Baylor Charles A. Sammons Cancer Center , Texas Oncology and US Oncology...
...Texas UnitedHealthcare Group (NYSE:UNH), Minnetonka, Minn. U.S. Food and Drug Administration (FDA), Silver Spring, Md. US Oncology...

...previously announced acquisition of US Oncology. The companies said the deal, which includes the assumption of US Oncology's...
...valued at $2.2 billion (see BioCentury, Nov. 8, 2010). McKesson Corp. (NYSE:MCK), San Francisco, Calif. US Oncology Inc....

...Healthcare services and information technology company McKesson will acquire oncology services company US Oncology to expand its...
...presence in the oncology market. The companies said the deal, which includes the assumption of US Oncology's...
...March 31, 2011, and slightly accretive beginning in FY12. McKesson Corp. (NYSE:MCK), San Francisco, Calif. US Oncology Inc....